Mylan subsidiary Agila Specialties has received a statement of good manufacturing practice (GMP) non-compliance from Poland’s Main Pharmaceutical Inspectorate at its Warsaw-based manufacturing site.

The regulations for food and drugs in the United States, described in Title 21 of the Code of Federal Regulations (CFR), are critical in ensuring safe and ethical drug administration. Whether you are ...

Life science companies must adhere to the FDA’s Good Manufacturing Practices (GMP) in manufacturing and storage of the product within their manufacturing facility. For example, GMP compliance is ...

A handful of statements of non-compliance with good manufacturing practice (GMP) have been posted to the EudraGMDP database, including ones sent to Spain’s Genfarma Laboratorio, Italy’s Biomedica ...

MONTREAL, Feb. 18, 2026 /PRNewswire/ - E-Biotech® today formally announced the launch of its patent-pending artificial intelligence infrastructure platform for pharmaceutical and GMP compliance, ...

Meta has tapped U.S. bond giant PIMCO and alternative asset manager Blue Owl Capital to spearhead a $29 billion financing for its data center expansion in rural Louisiana, a person familiar with the ...

HOLLISTON, Mass.--(BUSINESS WIRE)--Oligo Factory, a leading manufacturer of high-quality oligonucleotides at scale, announces today that it is compliant with current Good Manufacturing Practices (GMP) ...

ROCKVILLE, Md.--(BUSINESS WIRE)-- RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) announced that it has received a notice from the U.S. Food and Drug ...

MOUNTAIN VIEW, Calif., Aug. 21, 2012 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the company has received its EU Certificate of GMP Compliance of a Manufacturer.

The MarketWatch News Department was not involved in the creation of this content. MONTREAL, Feb. 18, 2026 /PRNewswire/ - E-Biotech(R) today formally announced the launch of its patent-pending ...